These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7105622)

  • 1. Pharmacologic reversal of hypotensive effect complicating antiarrhythmic therapy with bretylium.
    Woosley RL; Reele SB; Roden DM; Nies AS; Oates JA
    Clin Pharmacol Ther; 1982 Sep; 32(3):313-21. PubMed ID: 7105622
    [No Abstract]   [Full Text] [Related]  

  • 2. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
    Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful long-term suppression of previously refractory paroxysmal ventricular tachycardia with bretylium tosylate.
    Slack JD; Rizk AE; Wright KE
    Heart Lung; 1979; 8(4):721-7. PubMed ID: 378903
    [No Abstract]   [Full Text] [Related]  

  • 4. Bretylium tosylate: a review.
    Bryan CK; Darby MH
    Am J Hosp Pharm; 1979 Sep; 36(9):1189-92. PubMed ID: 386786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bretylium (Bretylol) for ventricular arrhythmias.
    Med Lett Drugs Ther; 1978 Dec; 20(24):105-6. PubMed ID: 713969
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with bretylium tosylate].
    Steffen V; Assmann I; Fiehring H
    Z Gesamte Inn Med; 1976 Sep; 31(17):684-8. PubMed ID: 793213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug corner: bretylium tosylate (Bretylol).
    Crit Care Nurse; 1980; 1(1):68-9. PubMed ID: 6914232
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe hypotension due to the use of bretylium for postcardiotomy ventricular arrhythmias.
    Kron IL; Nolan SP
    Ann Thorac Surg; 1983 Mar; 35(3):271-3. PubMed ID: 6600915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bretylium in severe ventricular arrhythmias associated with digitalis intoxication.
    Vincent JL; Dufaye P; Berre J; Kahn RJ
    Am J Emerg Med; 1984 Nov; 2(6):504-6. PubMed ID: 6529463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.
    Dhurandhar RW; Pickron J; Goldman AM
    Heart Lung; 1980; 9(2):265-70. PubMed ID: 6898604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: clinical application of a new assay for bretylium.
    Anderson JL; Patterson E; Wagner JG; Johnson TA; Lucchesi BR; Pitt B
    J Cardiovasc Pharmacol; 1981; 3(3):485-99. PubMed ID: 6168830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate.
    Bacaner MB
    Am J Cardiol; 1968 Apr; 21(4):530-43. PubMed ID: 5650734
    [No Abstract]   [Full Text] [Related]  

  • 13. Life threatening ventricular dysrhythmias: intervention with bretylium tosylate.
    Sullivan HE; Wehner RJ
    AANA J; 1983 Jun; 51(3):284-9. PubMed ID: 6613506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bretylium and dobutamine in the treatment of coronary artery disease.
    Frishman WH
    Bull N Y Acad Med; 1979 Sep; 55(8):798-809. PubMed ID: 290401
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bretylium tosylate as an anti-arrhythmic drug].
    Steffen V; Fiehring H
    Z Gesamte Inn Med; 1976 Nov; 31(22):913-9. PubMed ID: 798429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of bretylium tosylate against refractory ventricular arrhythmias.
    Bernstein JG; Koch-Weser J
    Circulation; 1972 May; 45(5):1024-34. PubMed ID: 4553611
    [No Abstract]   [Full Text] [Related]  

  • 17. Bretylium tosylate in patients with acute myocardial infarction.
    Torresani J
    Am J Cardiol; 1984 Jul; 54(2):20A-25A. PubMed ID: 6464996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of bretylium to suppress inducible ventricular tachycardia.
    Greene HL; Werner JA; Gross BW; Sears GK
    Am Heart J; 1983 May; 105(5):717-21. PubMed ID: 6846114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of refractory ventricular tachycardia and fibrillation by bretylium tosylate: a report of 4 cases].
    Li SZ; Xu XH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Aug; 15(4):203-4, 12. PubMed ID: 3440418
    [No Abstract]   [Full Text] [Related]  

  • 20. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.